BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2021 9:33:19 AM | Browse: 726 | Download: 1410
 |
Received |
|
2021-05-07 05:04 |
|
Peer-Review Started |
|
2021-05-07 05:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-15 21:44 |
|
Revised |
|
2021-06-21 03:38 |
|
Second Decision |
|
2021-08-04 03:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-04 08:37 |
|
Articles in Press |
|
2021-08-04 08:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-08-19 06:18 |
|
Publish the Manuscript Online |
|
2021-08-20 09:33 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Prajna Anirvan, Shivaram P Singh, Alexa Giammarino and Sanjaya K Satapathy |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sanjaya K Satapathy, FAASLD, AGAF, FACG, FASGE, MBBS, MD, MS, Attending Doctor, Director, Director, Professor, Division of Hepatology at Sandra Atlas Bass Center for Liver Diseases and Transplantation, Donald and Barbara Zucker School of Medicine at Hofstra, Northwell Health, 400 Community Drive, Manhasset, NY 11030, United States. ssatapat@northwell.edu |
| Key Words |
SARS-CoV-2; Fatty liver; Mitochondria; Nitrosative stress; Oxidative stress; COVID-19; Metabolic associated fatty liver disease; Nonalcoholic fatty liver disease; Progressive liver disease; Nonalcoholic steatohepatitis |
| Core Tip |
Liver injury in the form of elevated transaminases and hyperbilirubinemia in coronavirus disease 2019 (COVID-19) may be attributed to multiple factors, including the presence of pre-existing liver disease. The presence of nonalcoholic fatty liver disease (NAFLD) in patients with COVID-19 is likely to make them susceptible to severe forms of liver injury. Given the high prevalence of NAFLD worldwide, it is important to understand the implications of COVID-19 in such patients including role of comorbidities, disease progression, and the severity of COVID-19. |
| Publish Date |
2021-08-20 09:33 |
| Citation |
Anirvan P, Singh SP, Giammarino A, Satapathy SK. Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence. World J Hepatol 2021; 13(8): 916-925 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i8/916.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i8.916 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
